Depletion by 1,2-dibromoethane, 1,2-dibromo-3-chloropropane, tris(2,3-dibromopropyl)phosphate, and hexachloro-1,3-butadiene of reduced non-protein sulfhydryl groups in target and non-target organs.
D000758:Anesthesia; D000818:Animals; D002070:Butadienes / Q000494:pharmacology; D015946:Ethylene Dibromide / Q000494:pharmacology; D006846:Hydrocarbons, Halogenated / Q000494:pharmacology*; D007511:Ischemia / Q000378:metabolism; D008297:Male; D051379:Mice; D008813:Mice, Inbred ICR; D009928:Organ Specificity; D010755:Organophosphates / Q000494:pharmacology; D010084:Oxidation-Reduction; D010882:Piperonyl Butoxide / Q000494:pharmacology; D011078:Polychlorinated Biphenyls / Q000494:pharmacology; D011335:Proadifen / Q000494:pharmacology; D011407:Propane / Q000031:analogs & derivatives / Q000494:pharmacology; D051381:Rats; D011916:Rats, Inbred F344; D013438:Sulfhydryl Compounds / Q000378:metabolism*
D002070:Butadienes; D006846:Hydrocarbons, Halogenated; D010755:Organophosphates; D013438:Sulfhydryl Compounds; C012085:tris(2,3-dibromopropyl)phosphate; D015946:Ethylene Dibromide; C007318:1,2-dibromo-3-chloropropane; D011335:Proadifen; C001335:hexachlorobutadiene; D011078:Polychlorinated Biphenyls; D010882:Piperonyl Butoxide; D011407:Propane